title: Advances in experimental systems to study hepatitis C virus in vitro and in vivo.
abstract: Hepatitis C virus (HCV) represents a global health concern affecting over 185 million people worldwide. Chronic HCV infection causes liver fibrosis and cirrhosis and is the leading indication for liver transplantation. Recent advances in the field of direct-acting antiviral drugs (DAAs) promise a cure for HCV in over 90% of cases that will get access to these expensive treatments. Nevertheless, the lack of a protective vaccine and likely emergence of drug-resistant viral variants call for further studies of HCV biology. With chimpanzees being for a long time the only non-human in vivo model of HCV infection, strong efforts were put into establishing in vitro experimental systems. The initial models only enabled to study specific aspects of the HCV life cycle, such as viral replication with the subgenomic replicon and entry using HCV pseudotyped particles (HCVpp). Subsequent development of protocols to grow infectious HCV particles in cell-culture (HCVcc) ignited investigations on the full cycle of HCV infection and the virus-host interactions required for virus propagation. More recently, small animal models permissive to HCV were generated that allowed in vivo testing of novel antiviral therapies as well as vaccine candidates. This review provides an overview of the currently available in vitro and in vivo experimental systems to study HCV biology. Particular emphasis is given to how these model systems furthered our understanding of virus-host interactions, viral pathogenesis and immunological responses to HCV infection, as well as drug and vaccine development.
authors.affiliation: Division of Infectious Diseases, King׳s College London, London, United Kingdom. Electronic address: maria.catanese@kcl.ac.uk.
authors.forename: Maria Teresa
authors.initials: MT
authors.lastname: Catanese
authors.affiliation: Section of Virology, Imperial College London, London, United Kingdom; Section of Hepatology, Imperial College London, London, United Kingdom. Electronic address: m.dorner@imperial.ac.uk.
authors.forename: Marcus
authors.initials: M
authors.lastname: Dorner
mesh_terms: D000818:Animals; D002460:Cell Line; D004195:Disease Models, Animal; D016174:Hepacivirus / Q000472:pathogenicity / Q000502:physiology*; D054884:Host-Pathogen Interactions; D006801:Humans; D002679:Pan troglodytes
keywords: Animal models; Cell culture-derived HCV; Hepatitis C virus; Hepatocye-based models; Model systems; Pseudoparticles; Replicon; Soluble E2